These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):571-9. PubMed ID: 7499672 [Abstract] [Full Text] [Related]
3. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M, Braillon P, Karlström R. Thorax; 2001 Apr; 56(4):272-8. PubMed ID: 11254817 [Abstract] [Full Text] [Related]
4. Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months. Wang WQ, Ip MS, Tsang KW, Lam KS. J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):445-50. PubMed ID: 9564795 [Abstract] [Full Text] [Related]
13. Long-term influence of inhaled corticosteroids on bone metabolism and density. Are biological markers predictors of bone loss? Boulet LP, Milot J, Gagnon L, Poubelle PE, Brown J. Am J Respir Crit Care Med; 1999 Mar; 159(3):838-44. PubMed ID: 10051260 [Abstract] [Full Text] [Related]
18. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Hughes JA, Conry BG, Male SM, Eastell R. Thorax; 1999 Mar; 54(3):223-9. PubMed ID: 10325897 [Abstract] [Full Text] [Related]